The need for a center-tailored treatment protocol for peritonitis

Peritoneal Dialysis International

Volumn 18, Issue 3, 1998, Pages 274-281

  Van Biesen, Wim ^a   Vanholder, Raymond ^a   Vogelaers, Dirk ^a   Peleman, Renaat ^a   Verschraegen, Gerda ^a   Vijt, Denise ^a   Lameire, Norbert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Microbiology; Peritonitis

Indexed keywords

CIPROFLOXACIN; GENTAMICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DIALYSATE; DISEASE COURSE; DRUG INDICATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; ORAL DRUG ADMINISTRATION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT PLANNING; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CLINICAL PROTOCOLS; DRUG THERAPY, COMBINATION; GENTAMICINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PERITONEAL DIALYSIS; PERITONITIS; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN;

EID: 0031880633     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Keane WF, Vas S. Peritonitis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic, 1994:473-501.
2. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7:2176-82.
3. Advisory Committee on Peritonitis Management of the International Society for Peritoneal Dialysis. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16:557-73.
4. De Fijter CWH, Oe PL, Van Der Meulen J, Verbrugh HA, Ter Wee PM, Verhoef J, et al. A dramatic decrease in complicated peritonitis episodes due to Staphylococcus epidermidis by changing the initial antibiotic treatment. In: Ota K, ed. Current concepts in peritoneal dialysis. Amsterdam: Elsevier, 1992:372-4.
5. Morse GD, Nairn DK, Walshe JJ. Once weekly intraperitoneal therapy for gram-positive peritonitis. Am J Kidney Dis 1987; 10(4):300-5.
6. Boyce NW, Wood C, Thomson NM, Kerr P, Atkins RC. Intraperitoneal vancomycin therapy for CAPD peritonitis: a prospective, randomized comparison of intermittent versus continuous therapy. Am J Kidney Dis 1988; 12:304-6.
7. Searle M, Raman GV. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis. Clin Nephrol 1985; 23:241-4.
8. Were AJ, Marsden A, Tooth A, Ramsden R, Mistry CD, Gokal R. Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients. Clin Nephrol 1992; 37:209-13.
9. Lameire N, Vogelaers D, Verschraegen G, Veys N. Vancomycin resistant enterococci: a threat to the nephrologist on the horizon? Glycopeptide-resistant enterococci and ICDC recommendations for a limited use of glycopeptides. Nephrol Dial Transpl 1996; 11:2402-6.
10. Morse GD, Farolino DF, Apicella MA, Walshe JJ. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1987; 31(2):173-7.
11. Tapson JS, Orr KE, George JC, Stansfield E, Bint AJ, Ward MK. A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmycin in CAPD peritonitis. J Antimicrob Chemother 1990; 26(Suppl F):63-71.
12. Bastani B, Freer K, Read D, Bailey S, Sherman RA, Davis M, et al. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients. Nephron 1987; 45:283-5.
13. Bailie GR, Eisele G. Vancomycin in peritoneal dialysis-associated peritonitis. Semin Dial 1996; 9:417-23.
14. Mulhern JG, Braden GL, O'Shea MH, Madden RL, Lipkowitz GS, Germain MJ. Through serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients. Am J Kidney Dis 1995; 25:611-15.
15. Lortholary O, Tod M, Cohen Y, Petitjean O. Aminoglycosides. Med Clin North Am 1995; 79:761-87.
16. Tulkens P. Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data. Scand J Infect Dis 1991; 74:249-57.
17. De Broe ME, Giuliano RA, Verpooten GA. Choice of drug and dosage regimen: Two important risk factors for aminoglycoside nephrotoxicity. Am J Med 1986; 80:115-18.
18. Bennet-Jones DN, Russell GI, Barrett A. A comparison between oral ciprofloxacin and intraperitoneal vancomycin and gentamycin in the treatment of CAPD peritonitis. J Antimicrob Chemother 1990; 26(Suppl F):73-6.
19. Fleming LW, Phillips G, Stewart WK, Scott AC. Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 25:441-8.
20. Cruciani M, Bassetti D. The fluoroquinolones as treatment for infections caused by gram-positive bacteria. J Antimicrob Chemother 1994; 33:403-17.
21. Nikolaidis P. Newer quinolones in the treatment of continuous ambulatory peritoneal dialysis related infections. Perit Dial Int 1990; 10:127-33.
22. Mrhar A, Karba R, Drinovec J, Primozic S, Varl J, Bren AF, et al. Computer simulation of ciprofloxacin pharmacokinetics in patients on CAPD. Int J Artif Organs 1990; 13:169-75.
23. Janknecht R. CAPD peritonitis and fluoroquinolones: a review. Perit Dial Int 1991; 11:53-8.
24. Hirszel P, Lameire N, Bogaert M. Pharmacologic alterations of peritoneal transport rates and pharmacokinetics of the peritoneum. In: The textbook of peritoneal dialysis. Gokal R, Nolph K, eds. Dordrecht: Kluwer Academic, 1994:161-232.
25. Finch RG, Edwards R, Filik R, Wilcox MH. Continuous ambulatory peritoneal dialysis peritonitis: The effect of antibiotics on the adherence of coagulase negative staphylococci to silicone rubber catheter material. Perit Dial Bull 1989; 9:103-5.
26. Dharmasena D, Roberts DE, Coles GA, Williams JD. Pharmacokinetics of intraperitoneal ciprofloxacin in patients on CAPD. J Antimicrob Chemother 1989; 23:253-9.
27. Ludlam HA, Barton I, White L, McMullin C, King A, Phillips I. Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 25:843-51.
28. Friedland JS, Iveson TJ, Fraise AP, Winearls CG, Selkon JB, Oliver DO. A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamycin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 26:77-81.
29. Dryden MS, Wing AJ, Phillips I. Low dose intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1991; 28:131-9.
30. Cometta A, Calandra T, Bille J, Glauser M. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia (Letter). N Engl J Med 1994; 330:1240.
31. Dratwa M, Glupczynski Y, Lameire N. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis 1991; 13(Suppl 7):S645-7.
32. Port F, Held P, Nolph K, Turenne M, Wolfe R. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992; 42:967-74.